14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -0.825 7 days ( -10.52 % )
Last Price $23.80 -2.52 %
High/ Low $23.70 - $24.56 15.82%
Chg 7 Days 12.83 % $21.09 $23.80
Chg 30 Days 14.29 % $20.82 $23.80
Chg 12 mos 5.10 % $22.64 $23.80
Trend - 3 mos -10.25 % Width: 53.07 %
Trend - 12 mos 22.14 % Width: 76.92 %
Pred. range - 3 mos $14.29 - $21.87 -39.96 % - -8.10 %
Pred. range - 12 mos $18.19 - $32.18 -23.56 % - 35.24 %
Short MA avg 3 mos Buy Apr 19, 2024 - 13 days
Long MA avg 3 mos Buy Apr 25, 2024 - 9 days
Short/Long MA avg 3 mos Buy Apr 30, 2024 - 6 days
Short MA avg 12 mos Buy Apr 26, 2024 - 8 days
Long MA avg 12 mos Buy Apr 26, 2024 - 8 days
Short/Long MA avg 12 mos Sell Mar 25, 2024 - 31 days
Pivot Short Sell May 06, 2024 - 2 days
Bollinger Buy May 02, 2024 - 4 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Castle Biosciences, Inc.

Castle Biosciences. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients w... CSTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT